These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3367874)

  • 21. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of tumor markers for screening and diagnosis (except prognostic and surveillance values) in primary bronchial cancers].
    Grivaux M
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S15-9. PubMed ID: 9229742
    [No Abstract]   [Full Text] [Related]  

  • 23. [Value of serial tumor markers for the detection of recurrences].
    Quoix E
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S27-9. PubMed ID: 9229745
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combination assay of tumor markers in predicting the effectiveness of chemotherapy in non-small lung cancer].
    Satoh H; Yano H; Suyama T; Hasegawa S
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):127-9. PubMed ID: 1346084
    [No Abstract]   [Full Text] [Related]  

  • 26. [Value of serial tumor markers for determining the prognosis and predicting treatment response and survival].
    Souquet PJ
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S20-2. PubMed ID: 9229743
    [No Abstract]   [Full Text] [Related]  

  • 27. [The significance of tumor-associated antigens in the diagnosis and therapeutic control of bronchial cancer].
    Gropp C; Luster W; Havemann K
    Prax Klin Pneumol; 1982 Dec; 36(12):491-9. PubMed ID: 7163127
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.
    Wu GP; Ba J; Zhao YJ; Wang EH
    Acta Cytol; 2007; 51(4):679-80. PubMed ID: 17718156
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
    Li J; Chen P; Mao CM; Tang XP; Zhu LR
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):141-8. PubMed ID: 23551358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sputum carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 levels in lung cancer diagnosis.
    Kalomenidis I; Dimakou K; Kolintza A; Vlami K; Papadakis M; Sotiropoulou C; Orphanidou D; Roussos C; Papiris S
    Respirology; 2004 Mar; 9(1):54-9. PubMed ID: 14982602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study].
    Leonardo E; Dogliotti C; Oliaro A
    Minerva Med; 1986 May; 77(22-23):977-80. PubMed ID: 3014380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
    Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic importance of tumor markers in lung cancer.
    Ulsperger E; Karrer K
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():21-31. PubMed ID: 3074224
    [No Abstract]   [Full Text] [Related]  

  • 34. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of usefulness of tumor markers in the management of lung cancer].
    Ariyoshi Y
    Rinsho Byori; 1989 Feb; 37(2):113-7. PubMed ID: 2733177
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic significance of carcinoembryonic antigen measurement in bronchial lavage fluids in bronchial carcinoma].
    Ma WL
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):349-50, 380-1. PubMed ID: 1964877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tumor markers in the diagnosis of lung cancer].
    Marel M; Bíbrová L; Melínová L; Potocková L; Svandová E
    Cas Lek Cesk; 1993 Feb; 132(4):108-12. PubMed ID: 7682476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer].
    Suzuki K; Reshad K; Takahashi Y; Morita H; Hirata T; Itoi K; Nakano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):625-31. PubMed ID: 2824900
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ca 19-9 and Ca 50 in the diagnosis of bronchial carcinoma: comparison with CEA].
    Pecchio F; Rapellino M; Oliaro A; Moscato D; Adamo R; Albertino B; Lo Faso C; Faga C; Borasio P
    Minerva Med; 1988 Mar; 79(3):183-6. PubMed ID: 2834670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
    Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.